Common Contracts
6 similar Sales Agreement contracts by Provention Bio, Inc., Dare Bioscience, Inc., INSMED Inc, others
SALES AGREEMENTSales Agreement • February 22nd, 2024 • INSMED Inc • Pharmaceutical preparations • New York
Insmed Incorporated, a Virginia corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows:
KURA ONCOLOGY, INC. COMMON STOCK SALES AGREEMENTSales Agreement • November 2nd, 2023 • Kura Oncology, Inc. • Pharmaceutical preparations • New York
Kura Oncology, Inc., a Delaware corporation (the “Company”), Leerink Partners LLC (“Leerink Partners”), as lead sales agent, and Cantor Fitzgerald & Co. (“Cantor”, and together with Leerink Partners, the “Agents”), as sales agent, confirm their agreement (this “Agreement”) as follows:
DARÉ BIOSCIENCE, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • March 31st, 2023 • Dare Bioscience, Inc. • Pharmaceutical preparations • New York
Daré Bioscience, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Stifel, Nicolaus & Company, Incorporated (“Stifel Nicolaus”) and Cantor Fitzgerald & Co. (“Cantor”; each individually an “Agent” and together, the “Agents”), as follows:
Provention Bio, Inc. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • February 26th, 2021 • Provention Bio, Inc. • Pharmaceutical preparations • New York
Provention Bio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (each individually, an “Agent” and collectively, the “Agents”), as follows:
VAXART, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • July 8th, 2020 • Vaxart, Inc. • Biological products, (no disgnostic substances) • New York
Provention Bio, Inc. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • August 2nd, 2019 • Provention Bio, Inc. • Pharmaceutical preparations • New York
Provention Bio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with SVB Leerink LLC and Cantor Fitzgerald & Co. (each individually, an “Agent” and collectively, the “Agents”), as follows:
